Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-27 Kewalramani Reshma CEO & President Sale 10b5-1 −1,668 $339.43 $566K 126,690
2023-04-27 Kewalramani Reshma CEO & President Sale 10b5-1 −38 $340.19 $13K 126,652
2023-04-14 SACHS BRUCE I Director Grant or award · Deferred Stock Units +131.47 $332.77 $44K 14,400.25
2023-04-14 MCKENZIE DIANA Director Grant or award · Deferred Stock Units +90.15 $332.77 $30K 3,117.52
2023-04-13 SACHS BRUCE I Director Gift 10b5-1 −1,210 40,000
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −874 $325.70 $285K 46,406
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −4,068 $326.45 $1.3M 42,338
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −2,625 $327.43 $860K 39,713
2023-04-12 SACHS BRUCE I Director Exercise or conversion 10b5-1 +21,300 $72.14 $1.5M 62,510
2023-04-12 SACHS BRUCE I Director Sale 10b5-1 −2,917 $325.65 $950K 59,593
2023-04-12 SACHS BRUCE I Director Sale 10b5-1 −10,357 $326.46 $3.4M 49,236
2023-04-12 SACHS BRUCE I Director Sale 10b5-1 −8,026 $327.48 $2.6M 41,210
2023-04-12 SACHS BRUCE I Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −21,300 0
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −211 $314.22 $66K 47,591
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −94 $315.66 $30K 47,497
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −90 $316.76 $29K 47,407
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −96 $317.65 $30K 47,311
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Sale 10b5-1 −31 $318.68 $10K 47,280
2023-03-31 Sanna Bastiano EVP, Cell & Genetic Therapies Shares withheld for taxes −1,466 $313.74 $460K 47,802
2023-03-31 Ambrose Kristen SVP & Chief Accounting Officer Shares withheld for taxes −176 $313.74 $55K 7,127

Page 31 of 40 · 781 trades